| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.662 | 1.541 | 2.314 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 4.662 | 1.541 | 2.314 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 4.812 | 1.663 | 2.350 | 2.008 | 461 | 419 | 326 | 12 | 0 | 0 |
| Gross Profit/Loss - EUR | -150 | -122 | -36 | -2.008 | -461 | -419 | -326 | -12 | 0 | 0 |
| Net Profit/Loss - EUR | -290 | -168 | -106 | -2.008 | -461 | -419 | -326 | -12 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Genecrist S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 1.065 | 988 | 914 | 840 | 843 | 840 | 835 |
| Current Assets | 1.058 | 1.570 | 878 | 473 | 291 | 82 | 112 | 100 | 100 | 99 |
| Inventories | 596 | 556 | 528 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 241 | 638 | 136 | 178 | 190 | 30 | 12 | 0 | 0 | 0 |
| Cash | 221 | 376 | 215 | 295 | 101 | 52 | 100 | 100 | 100 | 99 |
| Shareholders Funds | -1.681 | -1.832 | -1.907 | -1.255 | -1.693 | -2.229 | -2.505 | -2.525 | -2.517 | -2.503 |
| Social Capital | 495 | 490 | 482 | 473 | 464 | 455 | 445 | 446 | 445 | 442 |
| Debts | 2.739 | 3.402 | 2.785 | 2.794 | 2.971 | 3.225 | 3.457 | 3.468 | 3.457 | 3.438 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2562 - 2562" | |||||||||
| CAEN Financial Year |
2562
|
|||||||||
Comments - Genecrist S.r.l.